Time course global gene expression analysis of an in vivo Candida biofilm.

Candida infection of devices is common and invariably associated with biofilm growth. Exploratory microarray studies were undertaken to identify target genes associated with biofilm formation from an in vivo catheter model over time. We compared messenger RNA levels from Candida albicans grown in an in vivo central venous catheter biofilm model at 12 h (intermediate growth) and 24 h (mature) to in vitro planktonic cells without a biofilm substrate, using C. albicans oligo arrays. A total of 124 transcripts were similarly up-regulated at the 12- and 24-h time points. Ontology categories most highly represented included energy/metabolism (12%), carbohydrate (10%), and protein (13%) synthesis and modification, and transport (6%). Numerous genes were previously identified from in vitro biofilm studies. These genes included those associated with hyphal growth, amino acid metabolism, adherence, drug resistance, ergosterol biosynthesis, and beta-glucan synthesis. In the current data set, adherence genes were unique to those from the earlier time point. Differences between the current in vivo biofilm expression data and that previously reported from in vitro models, including alterations in metabolism and carbohydrate processing, may be due to the continuous availability of nutrients from host serum and the incorporation of the host-pathogen interaction.

[1]  A. Mitchell,et al.  Function of Candida albicans Adhesin Hwp1 in Biofilm Formation , 2006, Eukaryotic Cell.

[2]  B. Wickes,et al.  Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.

[3]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[4]  D. Andes,et al.  Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazole , 2006, Antimicrobial Agents and Chemotherapy.

[5]  M. Coen,et al.  Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-beta-glucosyltransferase. , 1997, Microbiology.

[6]  Mahmoud A. Ghannoum,et al.  Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.

[7]  K. Ying,et al.  cDNA Microarray Analysis of Differential Gene Expression in Candida albicans Biofilm Exposed to Farnesol , 2005, Antimicrobial Agents and Chemotherapy.

[8]  Omar Antar,et al.  Alcohol Dehydrogenase Restricts the Ability of the Pathogen Candida albicans To Form a Biofilm on Catheter Surfaces through an Ethanol-Based Mechanism , 2006, Infection and Immunity.

[9]  Xiaomin Zhao,et al.  Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. , 2005, Microbiology.

[10]  D. Andes,et al.  Beta -1,3 glucan as a test for central venous catheter biofilm infection. , 2007, The Journal of infectious diseases.

[11]  H. Tabuchi,et al.  Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis , 1997, Journal of bacteriology.

[12]  R. Donlan Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  L. J. Douglas,et al.  Biofilm formation by Candida species on the surface of catheter materials in vitro , 1994, Infection and immunity.

[14]  K. Oh,et al.  Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Regenberg,et al.  Dip5p mediates high-affinity and high-capacity transport of L-glutamate and L-aspartate in Saccharomyces cerevisiae , 1998, Current Genetics.

[16]  D. Andes,et al.  Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model , 2004, Infection and Immunity.

[17]  K. Nickerson,et al.  Quorum Sensing in the Dimorphic FungusCandida albicans Is Mediated by Farnesol , 2001, Applied and Environmental Microbiology.

[18]  A. Mitchell,et al.  Complementary Adhesin Function in C. albicans Biofilm Formation , 2008, Current Biology.

[19]  C. Mateus,et al.  Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole , 2004, Antimicrobial Agents and Chemotherapy.

[20]  Christophe d'Enfert,et al.  Stage‐specific gene expression of Candida albicans in human blood , 2003, Molecular microbiology.

[21]  L. J. Douglas,et al.  Candida biofilms and their role in infection. , 2003, Trends in microbiology.

[22]  S. Rupp,et al.  The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans , 2000, Molecular microbiology.

[23]  M. Ghannoum,et al.  Candida biofilms: antifungal resistance and emerging therapeutic options. , 2004, Current opinion in investigational drugs.

[24]  C. Lan,et al.  Genome-Wide Transcription Profiling of the Early Phase of Biofilm Formation by Candida albicans , 2005, Eukaryotic Cell.

[25]  M. Raymond,et al.  PDR16‐mediated azole resistance in Candida albicans , 2006, Molecular microbiology.

[26]  Gordon Ramage,et al.  The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. , 2002, FEMS microbiology letters.

[27]  G. Baillie,et al.  Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. , 2000, The Journal of antimicrobial chemotherapy.

[28]  G. Baillie,et al.  Production of extracellular matrix by Candida albicans biofilms. , 1998, Journal of medical microbiology.

[29]  A. Mitchell,et al.  Candida albicans Biofilm-Defective Mutants , 2005, Eukaryotic Cell.

[30]  B. Regenberg,et al.  Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae , 1999, Current Genetics.

[31]  D. Andes,et al.  Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance , 2006, Antimicrobial Agents and Chemotherapy.

[32]  G. Fink,et al.  Tyrosol is a quorum-sensing molecule in Candida albicans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Ghannoum,et al.  Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols , 2003, Infection and Immunity.

[34]  C. Kumamoto A contact-activated kinase signals Candida albicans invasive growth and biofilm development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Gerald R. Fink,et al.  The glyoxylate cycle is required for fungal virulence , 2001, Nature.

[36]  F. Rey,et al.  Characterization of the CaENG1 Gene Encoding an Endo-1,3-β-Glucanase Involved in Cell Separation in Candida albicans , 2005, Current Microbiology.

[37]  B. Wickes,et al.  Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. , 2002, The Journal of antimicrobial chemotherapy.

[38]  Marcelo D. Vinces,et al.  Alternative Candida albicans lifestyles: growth on surfaces. , 2005, Annual review of microbiology.

[39]  A. Johnson,et al.  Control of filament formation in Candida albicans by the transcriptional repressor TUP1. , 1997, Science.

[40]  D. Andes,et al.  A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. , 2005, The Journal of infectious diseases.

[41]  J. Lopez-Ribot,et al.  Candida Biofilms: an Update , 2005, Eukaryotic Cell.

[42]  D. Andes,et al.  Candida albicans biofilm development, modeling a host-pathogen interaction. , 2006, Current opinion in microbiology.

[43]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[44]  D. Andes,et al.  Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. , 2007, Antimicrobial agents and chemotherapy.

[45]  M. Bard,et al.  Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. , 2004, The Journal of antimicrobial chemotherapy.

[46]  N. Chauhan,et al.  The Two-Component Signal Transduction Protein Chk1p Regulates Quorum Sensing in Candida albicans , 2004, Eukaryotic Cell.

[47]  A. Mitchell,et al.  Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo , 2006, PLoS pathogens.

[48]  C. d’Enfert,et al.  Candida albicans Biofilms: a Developmental State Associated With Specific and Stable Gene Expression Patterns , 2004, Eukaryotic Cell.

[49]  A. Mitchell,et al.  Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions , 2008, Cellular microbiology.

[50]  R. Miller,et al.  A Small Subpopulation of Blastospores in Candida albicans Biofilms Exhibit Resistance to Amphotericin B Associated with Differential Regulation of Ergosterol and β-1,6-Glucan Pathway Genes , 2006, Antimicrobial Agents and Chemotherapy.